The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
NAFLD as a driver of chronic kidney disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide public health problems, affecting up to 25-30% (NAFLD), and up to 10-15% (CKD) of the general population. Recently, it has also been established that there is a strong association between NAFLD and CKD, regardless of the presence of potential confounding diseases such as obesity, hypertension and type 2 diabetes. Since NAFLD and CKD are both common diseases that often occur alongside other metabolic conditions, such as type 2 diabetes or metabolic syndrome, elucidating the relative impact of NAFLD on the risk of incident CKD presents a substantial challenge for investigators working in this research field. A growing body of epidemiological evidence suggests that NAFLD is an independent risk factor for CKD and recent evidence also suggests that associated factors such as metabolic syndrome, dysbiosis, unhealthy diets, platelet activation and processes associated with ageing could also contribute mechanisms linking NAFLD and CKD. This narrative review provides an overview of the literature on: a) the evidence for an association and causal link between NAFLD and CKD and b) the underlying mechanisms by which NAFLD (and factors strongly linked with NAFLD) may increase the risk of developing CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, there is uncertainty as to whether there is a direct causal link between MASLD and CKD as both diseases share common risk factors. 227”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [227]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,320
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Cited by
Sorted by citations
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 879
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Ferguson, D., & Finck, B. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00507-z · Cited by 520
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
Tilg, H., Adolph, T. E., & Moschen, A. R. (2020) · Hepatology · doi:10.1002/hep.31518 · Cited by 455
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut · doi:10.1136/gutjnl-2020-323082 · Cited by 402
Sun, D.-Q., Jin, Y., Wang, T.-Y., Zheng, K. I., Rios, R. S., Zhang, H.-Y., Targher, G., Byrne, C., Yuan, W., & Zheng, M. (2020) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2020.154433 · Cited by 294
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 365
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Martinez-Moreno, J. M., Monsalve, M., Ramos, A. M., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2020) · Biomolecules · doi:10.3390/biom10020347 · Cited by 303
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Kaya, E., & Yilmaz, Y. N. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00178 · Cited by 241
Sandireddy, R., Sakthivel, S., Gupta, P., Behari, J., Tripathi, M., & Singh, B. K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1433857 · Cited by 235
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
Steatotic liver disease, MASLD and risk of chronic kidney disease
Bilson, J., Mantovani, A., Byrne, C. D., & Targher, G. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101506 · Cited by 179
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Targher, G., Corey, K. E., & Byrne, C. D. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.101215 · Cited by 174
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Chan, K. E., Ong, E. Y. H., Chung, C. H., Ong, C. E. Y., Koh, B., Tan, D. J. H., Lim, W. H., Yong, J. N., Xiao, J., Wong, Z. Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.018 · Cited by 155
Muzurović, E., Peng, C. C., Belanger, M. J., Sanoudou, D., Mikhailidis, D. P., & Mantzoros, C. S. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.17982 · Cited by 141
Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Lu, F., Zheng, K. I., Rios, R. S., Targher, G., Byrne, C. D., & Zheng, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15156 · Cited by 116
Tanabe, H., Saito, H., Kudo, A., Machii, N., Hirai, H., Maimaituxun, G., Tanaka, K., Masuzaki, H., Watanabe, T., Asahi, K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072083 · Cited by 116
Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?
Chen, J., Deng, X., Liu, Y., Tan, Q., Huang, G., Che, Q., Guo, J., & Su, Z. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47143 · Cited by 118
Tang, A. S. P., Ng, C. H., Phang, P. H., Chan, K. E., Chin, Y. H., Fu, C. E., Zeng, R. W., Xiao, J., Tan, D. J. H., Quek, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.06.029 · Cited by 112
Duseja, A. K., Singh, S. P., De, A., Madan, K., Rao, P. N., Shukla, A., Choudhuri, G., Saigal, S., Shalimar, S., Arora, A., et al. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.014 · Cited by 107
Ratziu, V., Harrison, S. A., Loustaud-Ratti, V., Bureau, C., Lawitz, E., Abdelmalek, M., Alkhouri, N., Francque, S., Girma, H., Darteil, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.023 · Cited by 101
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
Guo, Z., Wu, D., Mao, R., Yao, Z., Wu, Q., & Lv, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-91312-5 · Cited by 100
Guo, W., Lü, J., Qin, P., Li, X., Zhu, W., Wu, J., Xu, N., & Zhang, Q. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01393-6 · Cited by 95
Sun, D., Targher, G., Byrne, C. D., Wheeler, D. C., Wong, V. W., Fan, J., Tilg, H., Yuan, W., Wanner, C., Gao, X., et al. (2023) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-22-421 · Cited by 94
Le, M. H., Le, D. M., Baez, T. C., Dang, H., Nguyen, V. H., Lee, K., Stave, C. D., Ito, T., Wu, Y., Yeo, Y. H., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0485 · Cited by 92
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Jennison, E., & Byrne, C. D. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0129 · Cited by 91
Parker, V. E. R., Hoang, T., Schlichthaar, H., Gibb, F. W., Wenzel, B., Posch, M. G., Rose, L., Chang, Y., Petrone, M., Hansen, L., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14712 · Cited by 80
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Kokkorakis, M., Muzurović, E. M., Volčanšek, Š., Chakhtoura, M., Hill, M. A., Mikhailidis, D. P., & Mantzoros, C. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001087 · Cited by 79
Lonardo, A., Mantovani, A., Targher, G., & Baffy, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113320 · Cited by 76
Song, S., Son, D., Baik, S. J., Cho, W. J., & Lee, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10092251 · Cited by 70
Hepatorenal Syndrome in Cirrhosis
Pose, E., Piano, S. S., Juanola, A., & Ginès, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2023.11.306 · Cited by 69
Non‐alcoholic fatty liver disease increases the risk of incident chronic kidney disease
Kaps, L., Labenz, C., Galle, P. R., Weinmann‐Menke, J., Kostev, K., & Schattenberg, J. M. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620944098 · Cited by 62
Riley, D. R. J., Hydes, T., Hernadez, G., Zhao, S. S., Alam, U., & Cuthbertson, D. J. (2024) · Liver International · doi:10.1111/liv.16016 · Cited by 64
Zhang, L., El-Shabrawi, M. H. F., Baur, L. A., Byrne, C. D., Targher, G., Kehar, M., Porta, G., Lee, W. S., Lefere, S., Turan, S., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.017 · Cited by 59
Frankowski, R., Kobierecki, M., Wittczak, A., Różycka-Kosmalska, M., Pietras, T., Sipowicz, K., & Kosmalski, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119677 · Cited by 58
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 58
Xie, W., Gan, J., Zhou, X., Tian, H., Pan, X., Liu, W., Li, X., Du, J., Xu, A., Zheng, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.020 · Cited by 55
Singh, A., Sohal, A., & Batta, A. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i48.5205 · Cited by 52
Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2022) · Biomolecules · doi:10.3390/biom12010105 · Cited by 51
MAFLD and CKD: An Updated Narrative Review
Mantovani, A., Lombardi, R., Cattazzo, F., Zusi, C., Cappelli, D., & Dalbeni, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137007 · Cited by 52
Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imaging
Mende, C. W., & EINHORN, D. F. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13232 · Cited by 52
Dua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 53
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0239 · Cited by 52
The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
Cao, Y., Deng, Y., Wang, J., Zhao, H., Zhang, J., & Xie, W. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211048649 · Cited by 46
Mantovani, A., Dalbeni, A., Beatrice, G., Cappelli, D., & Peralta, F. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040968 · Cited by 46
Seo, D. H., Suh, Y. J., Cho, Y., Ahn, S. H., Seo, S., Hong, S., Lee, Y., Choi, Y. J., Lee, E. J., & Kim, S. H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0130 · Cited by 48
Jung, C., Koh, H. B., Park, K. H., Joo, Y. S., Kim, H. W., Ahn, S. H., Park, J. T., & Kim, S. U. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101344 · Cited by 45
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
Basu, R., Noureddin, M., & Clark, J. M. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.04.005 · Cited by 45
Gangopadhyay, A., Ibrahim, R., Theberge, K., May, M. A., & Houseknecht, K. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042442 · Cited by 50
NAFLD in type 1 diabetes: overrated or underappreciated?
Mertens, J., Gaal, L. F. V., Francque, S., & Block, C. E. M. D. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211055557 · Cited by 44
Agustanti, N., Soetedjo, N. N. M., Damara, F. A., Iryaningrum, M. R., Permana, H., Bestari, M. B., & Supriyadi, R. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102780 · Cited by 43
Deng, Y., Zhao, Q., & Gong, R. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s292926 · Cited by 41
Chen, S., Pang, J., Huang, R., Xue, H., & Chen, X. (2023) · Hepatology International · doi:10.1007/s12072-023-10486-0 · Cited by 42
Roderburg, C., Krieg, S., Krieg, A. H., Demir, M., Luedde, T., Kostev, K., & Loosen, S. H. (2023) · European journal of medical research · doi:10.1186/s40001-023-01114-6 · Cited by 41
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Lubel, J. S., Hodge, A., & Roberts, S. K. (2023) · Nutrients · doi:10.3390/nu15030687 · Cited by 45
Lipid Disorders in NAFLD and Chronic Kidney Disease
Yang, M., Geng, C., Liu, X., & Guan, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101405 · Cited by 44
Renoprotective role of bariatric surgery in patients with established chronic kidney disease
Morales, E., Porrini, E., Martín-Taboada, M., Lima, S. L., Vila‐Bedmar, R., de Pablos, I. G., Gómez, P., Rodríguez, E., Torres, L., Lanzón, B., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa266 · Cited by 41
Altshuler, P. J., Shah, A. P., Frank, A. M., Glorioso, J. M., Dang, H. T., Shaheen, O., Patel, K., Ramirez, C. B., Maley, W. R., & Bodzin, A. S. (2021) · Transplant International · doi:10.1111/tri.13891 · Cited by 39
Li, M., Zhao, Z., Qin, G., Chen, L., Lu, J., Huo, Y., Chen, L., Zeng, T., Xu, M., Chen, Y., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154874 · Cited by 39
Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment
Pan, X. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_9 · Cited by 39
Deng, M., Wen, Y., Yan, J., Fan, Y., Wang, Z., Zhang, R., Ren, L., Ba, Y., Wang, H., Lü, Q., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03129-6 · Cited by 40
Zhang, M., Lin, S., Wang, M.-F., Huang, J., Liu, S., Wu, S., Zhang, H., Wu, Z., Liu, W., Zhang, D.-C., et al. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01278-z · Cited by 40
Targher, G., Mantovani, A., Grander, C., Foco, L., Motta, B. M., Byrne, C. D., Pramstaller, P. P., & Tilg, H. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.037 · Cited by 37
Bilson, J., Sethi, J. K., & Byrne, C. D. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003815 · Cited by 37
Mantovani, A., Morieri, M. L., Aldigeri, R., Palmisano, L., Masulli, M., Bonomo, K., Baroni, M. G., Cossu, E., Cimini, F. A., Cavallo, M. G., et al. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101497 · Cited by 39
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
Lin, Y., Wu, C.-C., & Ni, Y. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.603654 · Cited by 38
Yeh, H., Chiang, C.-C., & Yen, T. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4104 · Cited by 39
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Kosmalski, M., Frankowski, R., Ziółkowska, S., Różycka-Kosmalska, M., & Pietras, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051852 · Cited by 38
Gurun, M., Brennan, P., Handjiev, S., Khatib, A., Leith, D., Dillon, J. F., & Byrne, C. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299507 · Cited by 38
Cho, Y., Chang, Y., Ryu, S., Jung, H. S., Kim, C., Oh, H., Kim, M. K., Sohn, W., Shin, H. C., Wild, S. H., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1975 · Cited by 36
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
Lonardo, A., Ballestri, S., Mantovani, A., Targher, G., & Bril, F. (2024) · Metabolites · doi:10.3390/metabo14010040 · Cited by 34
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease
Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021) · American Journal of Nephrology · doi:10.1159/000518111 · Cited by 34
Big data and machine learning to tackle diabetes management
Pina, A. F., Meneses, M. J., Sousa‐Lima, I., Henriques, R., Raposo, J. F., & Macedo, M. P. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13890 · Cited by 32
Tripodi, A., Lombardi, R., Primignani, M., Mura, V. L., Peyvandi, F., & Fracanzani, A. L. (2022) · Biomedicines · doi:10.3390/biomedicines10020249 · Cited by 33
Miyamori, D., Tanaka, M., Sato, T., Endo, K., Mori, K., Mikami, T., Hosaka, I., Hanawa, N., Ohnishi, H., & Furuhashi, M. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030269 · Cited by 34
Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
Cai, X., Sun, L., Liu, X., Zhu, H., Zhang, Y., Zheng, S., & Huang, Y. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211024361 · Cited by 32
Bilson, J., Scorletti, E., Bindels, L. B., Afolabi, P. R., Targher, G., Calder, P. C., Sethi, J. K., & Byrne, C. D. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00170-3 · Cited by 30
Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.02.010 · Cited by 33
Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease
Jiang, F., Wang, L., Ying, H., Sun, J., Zhao, J., Lü, Y., Bian, Z., Chen, J., Fang, A., Zhang, X., et al. (2024) · Med · doi:10.1016/j.medj.2024.07.013 · Cited by 34
Godoy‐Matos, A. F., Valério, C. M., Júnior, W. S. D. S., Neto, J. M. D. A., Sposito, A. C., & Suassuna, J. H. R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01796-4 · Cited by 43
Mikolašević, I., Rahelić, D., Wensveen, T. T., Ruzic, A., Domislović, V., Hauser, G., Matić, T., Radić-Krišto, D., Krznarić, Ž., Radić, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108884 · Cited by 31
Cao, Y., Du, Y., Jia, W., Ding, J. H., Yuan, J., Zhang, H., Zhang, X., Tao, K., & Yang, Z.-X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125829 · Cited by 31
Wang, Y., Li, Y., Liu, K., Han, X., Dong, Y., Wang, X., Wang, M., Cong, L., Zhang, Q., Tang, S. H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15416 · Cited by 30
Braude, M. R., Roberts, S. K., Majeed, A., Lubel, J. S., Prompen, J., Dev, A. T., Sievert, W., Bloom, S., Gow, P. J., & Kemp, W. W. (2022) · Liver International · doi:10.1111/liv.15415 · Cited by 29
Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH)
Li, X., Bhattacharya, D., Yuan, Y., Wei, C., Zhong, F., Ding, F., D’Agati, V. D., Lee, K., Friedman, S. L., & He, C. (2023) · Kidney International · doi:10.1016/j.kint.2023.12.009 · Cited by 30
Abbate, M., Mascaró, C. M., Montemayor, S., Barbería-Latasa, M., Casares, M., Gómez, C., Angullo-Martínez, E., Tejada, S., Abete, I., Zulet, M. Á., et al. (2021) · Nutrients · doi:10.3390/nu13020629 · Cited by 30
Männistö, V., Salomaa, V. V., Färkkilä, M. A., Jula, A., Männistö, S., Erlund, I., Sundvall, J., Lundqvist, A., Perola, M., & Åberg, F. O. (2021) · Liver International · doi:10.1111/liv.15004 · Cited by 29
Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
Wang, Y., Yu, Y.-T., Zhang, H., Chen, C., Wan, H., Chen, Y., Xia, F., Yu, S., Wang, N., Ye, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.968766 · Cited by 31
Mori, K., Tanaka, M., Sato, T., Akiyama, Y., Endo, K., Ogawa, T., Suzuki, T., Aida, H., Kawaharata, W., Nakata, K., et al. (2024) · Hepatology Research · doi:10.1111/hepr.14097 · Cited by 29
Curcumin analogue C66 attenuates obesity-induced renal injury by inhibiting chronic inflammation
Lin, Y., Hu, X., Hu, X., Yin, S., Chen, J., He, H., Hong, S., Yang, B., Singh, K. K., Feng, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111418 · Cited by 28
Jung, C., Ryu, G. W., Kim, H. W., Ahn, S. H., Kim, S. U., & Kim, B. S. (2021) · Diabetologia · doi:10.1007/s00125-021-05627-9 · Cited by 28
Qiu, S., Chen, J., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Nutrients · doi:10.3390/nu14132749 · Cited by 28
Fernández, T., Briceño, F. A. C., Espinosa‐Ramírez, M., García-Valdés, P., López‐Fuenzalida, A., Riquelme, A. J., Arab, J. P., Cabrera, D., Arrese, M. A., & Francisco Barrera, M. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1810563 · Cited by 28
Nie, T., Wang, X., Li, A., Shan, A. S., & Ma, J. (2023) · Food & Function · doi:10.1039/d3fo04348g · Cited by 27
Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
Sessa, A. D., Umano, G. R., Cirillo, G., Passaro, A. P., Verde, V. L., Cozzolino, D., Guarino, S., Marzuillo, P., & del Giudice, E. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i36.5474 · Cited by 27
Metadata
- Authors
- Byrne, C. D., & Targher, G.
- Affiliations
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Verona (IT)
- Corresponding author
- Byrne, Christopher D.
- Targher, Giovanni
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 72
- Issue
- 4
- Pages
- 785-801
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3006576880
- Cited by
- 449
- References
- 144
- Citations by year
- 2026: 45 · 2025: 72 · 2024: 76 · 2023: 85 · 2022: 79 · 2021: 57 · 2020: 34
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Funders
- NIHR Bristol Biomedical Research Centre (IS-BRC-20004)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, chronic kidney disease, CKD risk factors, metabolic syndrome, dysbiosis, platelet activation, aging, type 2 diabetes, obesity, hypertension, unhealthy diet, pathophysiological mechanisms
- MeSH terms
- Adolescent, Adult, Aging, Child, Diabetes Mellitus, Type 2, Diet, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Platelet Activation, Comorbidity, Prevalence, Metabolic Syndrome, Renal Insufficiency, Chronic, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
